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Abstract
Venous oxygen saturation (Yv) in cerebral veins and the cerebral metabolic rate of oxygen
(CMRO2) are important indicators for brain function and disease. Although MRI has been used for
global measurements of these parameters, currently there is no established technique to quantify
regional Yv and CMRO2 using noninvasive imaging. This paper proposes a technique to quantify
CMRO2 from independent MRI estimates of Yv and cerebral blood flow (CBF). The approach
uses standard gradient-echo (GRE) and arterial spin labeling (ASL) acquisitions to make these
measurements. Using MR susceptometry on gradient-echo phase images, Yv was quantified for
candidate vein segments in gray matter that approximate a long cylinder parallel to the main
magnetic field. Local CBF for the identified vessel was determined from a corresponding region in
the ASL perfusion map. Fick’s principle of arteriovenous difference was then used to quantify
CMRO2 locally around each vessel. Application of this method in young, healthy subjects
provided gray matter averages of 59.6 ± 2.3% for Yv, 51.7 ± 6.4 ml/100g/min for CBF, and 158 ±
18 μmol/100g/min for CMRO2 (mean ± SD, n=12), which is consistent with values previously
reported by PET and MRI.
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INTRODUCTION
Venous oxygen saturation (Yv) and the cerebral metabolic rate of oxygen (CMRO2) are
important indicators of tissue viability in the brain. The brain consumes 20% of total body
energy through aerobic metabolism under normal conditions (1,2), and absolute
measurements of CMRO2 and Yv are linked to underlying cerebral physiology (3,4).
Regional estimates of these parameters would provide new information about normal
cerebral physiology during functional activity (5,6) and aging as well as modulation in
disease states of the brain, including stroke, tumor, and Alzheimer’s disease (7–9).
Address correspondence to: Audrey Fan, 32 Vassar Street, Room 36-792, Massachusetts Institute of Technology, Cambridge, MA
02142, TEL: (617) 324-1957, FAX: (617) 324-3644, apfan@mit.edu.
NIH Public Access
Author Manuscript
Magn Reson Med. Author manuscript; available in PMC 2013 March 1.
Published in final edited form as:
Magn Reson Med. 2012 March ; 67(3): 669–678. doi:10.1002/mrm.23050.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Currently, there is no established method to quantify regional Yv and CMRO2 with MRI in
vivo. Literature values for Yv and CMRO2 have been reported by positron emission
tomography (PET) studies, most commonly with 15O-labeled radiotracers(10–14). Although
PET imaging can detect regional differences in these parameters during normal brain
activity and in disease (7–9), it is a low spatial-resolution technique compared to MRI. In
addition, PET has not been routinely used in the clinic because it involves injection of a
radioactive label, which requires equipment that is not widely available. MRI-based methods
have been proposed to measure relative changes in oxygen metabolism, including the
combination of fMRI BOLD and cerebral blood flow (CBF) measurements for estimates of
CMRO2 changes in the brain during functional activation (15). These calibrated fMRI
techniques, however, do not offer absolute quantification of the parameters of interest and
depend on a functional task or physiological challenge such as hypercapnia to detect
changes from a physiological baseline (15).
Alternate approaches for quantitative measurements of Yv and CMRO2 have been proposed
using MRI (16,17). These methods estimate oxygen saturation in large draining veins in the
brain, such as the sagittal sinus, which represents aggregate vascular output from the whole
brain. Among the proposed techniques, T2-relaxation-under-spin-tagging (TRUST), obtains
an absolute measure of Yv from a blood T2 measurement within the vessel through an in
vitro calibration curve (16). Separately, Jain et al. determined Yv from susceptibility
differences between the sagittal sinus and the surrounding tissue (17) as estimated from MRI
phase images. This susceptibility shift reflects the innate paramagnetic effect of
deoxyhemoglobin in veins, which depends on the blood oxygenation level. Both techniques
rely on phase-contrast MRI to measure blood flow velocity in the vein of interest, from
which cerebral blood flow (CBF) is determined with an additional estimate of cerebral blood
volume. Fick’s principle of arteriovenous difference is then used calculate an absolute whole
brain estimate of CMRO2 in the draining vessel from Yv and CBF (18,19). In contrast,
estimates of regional oxygen metabolism with MRI require a robust method for local
measurements of oxygen saturation. A recently proposed MRI approach, QUantitative
Imaging of eXtraction of Oxygen and TIssue Consumption (QUIXOTIC), is a T2-based
technique to quantitatively map cerebral Yv (20). QUIXOTIC targets signal from post-
capillary venous blood in the brain using velocity-selective arterial spin labeling, and can
potentially generate maps of CMRO2 in the brain.
Here we develop a separate technique by extending susceptibility-based measurements of
oxygenation to quantify regional CMRO2 in the brain. Using gradient-echo phase maps,
local Yv was determined in segments of gray matter veins that fit our assumptions about
vessel geometry and orientation. Such vessel segments had length much longer than
diameter and were approximately parallel to the main magnetic field. In addition, CBF was
measured using arterial spin labeling (ASL), which uses a noninvasive tagging scheme to
magnetically label arterial blood flowing into an imaging slice. ASL provides spatial
information about CBF in a quantitative perfusion map, from which local CBF was
determined around candidate vessels. CMRO2 was then quantified on a regional basis from
these local measures of CBF and Yv using the Fick principle. This technique is termed
phase-based regional oxygen metabolism (PROM). Results are presented for gray matter Yv
and CMRO2 using this method in human subjects at 3 Tesla.
METHODS
Theory for Yv measurements
The proposed technique uses MR susceptometry to quantify the susceptibility difference
between candidate cerebral veins and the surrounding brain parenchyma from axial phase
images. Haacke et al. and Fernandez-Seara et al. applied MR susceptometry to estimate Yv
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in cerebral pial veins and the internal jugular vein, respectively (21,22). This measurement is
based on the field difference between the vein and tissue, ΔBvein-tissue, which manifests in
the phase image as Δϕ = γ·ΔB·TE, where γ is the gyromagnetic ratio and TE is the echo
time. We restricted our analysis to through-plane vessels parallel to the main magnetic field
(B0), with a diameter much smaller than the length of the vessel segment (Fig. 1). For the
purpose of estimating the local susceptibility difference between vein and tissue, such vessel
segments can be approximated as an infinite cylinder, and the susceptibility shift Δχvein-tissue
is determined as (21–23):
[1]
where θ is the angle between the vein and the main magnetic field, i.e. θ=0 when the vessel
is parallel to B0. Yv can be quantified from this susceptibility difference as (21):
[2]
where Δχdo = 0.18 ppm (cgs) is the susceptibility difference per unit hematocrit between
fully deoxygenated and fully oxygenated blood (23), and the tissue was assumed to have the
same susceptibility as fully oxygenated blood. Literature values were assumed for
hematocrit, Hct = 0.42 for males and Hct = 0.38 for females (24).
Theory for CMRO2 measurements
The Fick principle relates cerebral blood flow, the arteriovenous oxygenation gradient, and
oxygen consumption as (18,19):
[3]
where Ya is arterial oxygen saturation, CBF is perfusion of blood in brain tissue in ml/100g/
min, and Ca is the carrying capacity of oxygen molecules per volume of blood in μmol
O2/100ml. Assuming a normal mean corpuscular hemoglobin concentration (MCHC) in red
blood cells of 34g/dl (25), the concentration of hemoglobin in blood can be calculated from
the assumed hematocrit as [Hb] = MCHC · Hct. For a typical carrying capacity of 55.6μmol
O2 per gram of hemoglobin (24), Ca was determined to be 793 μmol O2/100ml blood for
males and 718 μmol O2/100ml blood for females. We also assumed that arterial blood is
fully saturated under normal conditions, i.e. Ya = 100%.
Here, we obtained local estimates of CMRO2 by combining Yv measurements from MR
susceptometry in candidate gray matter veins with local CBF measurements from ASL in
the region around the vessel. ASL provides information about the spatial distribution of
perfusion, and we used a PICORE-Q2TIPS acquisition that has been demonstrated to
mitigate errors from transit delays in tagged arterial spins and signal contamination from
venous blood (26).
Experiments
Experiments were performed on a 3 Tesla Tim-Trio magnet with a 32-channel receive head
coil. A total of 12 healthy volunteers (6 female, 6 male, age 26±5 years) participated with
approval of the Institutional Review Board for our institution and informed consent from
each subject.
For each subject, 2D, flow-compensated FLASH images were acquired at three echo times
(TE) of 10, 15, and 20ms. Both magnitude and phase were collected for 10 axial slices,
resolution = 0.5 × 0.5 × 2.0 mm3, field of view (FOV) = 217 × 224 mm, repetition time (TR)
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= 270 ms, flip angle (FA) = 25°, bandwidth = 150 Hz/Pixel. A separate scan with acquisition
time of approximately 6 minutes was collected for each TE.
For ASL, an EPI-based PICORE-Q2TIPS acquisition was used to obtain quantitative CBF
maps in 5 slices with coverage matched to that of the FLASH scans. The scan parameters
were: resolution = 2.0 × 2.0 × 4.0 mm3, FOV = 220 × 220 mm, TR = 2300 ms, inflow times
TI1/TI2 = 700/1800 ms, TE = 25 ms, bandwidth = 1570 Hz/Pixel. TI1 and TI2 were selected
from a reported optimal range to avoid contamination from arteries and signal loss due to T1
decay that could create error in calculations of absolute perfusion (26). As part of the ASL
acquisition, a measurement of the fully relaxed longitudinal magnetization of local tissue
(M0T) was made on a voxel-by-voxel basis. To calibrate the CBF measurement, a map of
M0B was calculated by scaling the map of M0T with the blood-brain partition coefficient,
λ=1.04, as M0B = M0T/λ. The total scan time was approximately 7 minutes for acquisition of
90 ASL control-tag pairs.
Data analysis
Candidate through-plane veins in the gray matter were manually identified by tracing
vessels through several axial slices to verify their superior-inferior orientation relative to B0
(Fig. 2a–b). For further assurance, the vessels were also typically view in the sagittal
orientation, as presented in Fig. 1, to confirm the long-cylinder approximation. Previous
work by Langham et al. (27) has demonstrated the validity of MR susceptometry with this
long, parallel cylinder model on vessels with length approximately 6 times the diameter. Our
own simulations revealed less than 5% oxygenation error in Yv estimates for veins with
length-to-diameter ratio of 4.
The FLASH phase images were high-pass filtered to remove background field
inhomogeneities that cause low-frequency spatial variations in the phase. A homodyne high
pass filter was implemented by dividing the original complex signal by a low-pass filtered
version of the image (32×32 Hanning filter), as described by Wang et al (28). This process
effectively removed phase-wraps in the image and mitigated global variations in phase that
could contribute bias to Yv quantification. Because vessels of interest were spatially narrow
(~1–2 pixel diameter), the measured phase difference between the vein and surrounding
tissue is expected to be robust to a kernel size on the order of 30 pixels.
To evaluate potential bias from the adopted high pass filter size on our Yv estimates,
simulations were performed on a representative narrow vessel parallel to B0. The simulated
vein had a diameter of 1mm and a susceptibility value corresponding to an underlying
oxygenation of Yv = 60% and Hct = 0.40. The vessel was simulated within a brain structure
created using an anatomical brain mask, where χtissue = −9.05ppm was the assumed
susceptibility value of brain parenchyma and χair = 0.36ppm was the assumed susceptibility
of air outside of the head (29). The background field was then calculated from the created
susceptibility distribution using multiplication with the dipole kernel in Fourier space (30),
and a sagittal slice from the resulting field distribution is depicted in Fig 3a. Simulated phase
images with contributions from both the background field and simulated parallel vessel were
generated for TE = 10, 15, and 20 ms. High pass filtering was then performed on one axial
slice at each TE for Hanning filter sizes of NxN = 4×4, 8×8, 16×16, and 32×32. Fig. 3
illustrates an axial phase slice simulated for TE = 10ms, and the corresponding ROI
containing the vessel for each filter size. Yv estimates were made from the simulated phase
difference between the vein and tissue for each filter size using the fitting procedure
described below (Fig. 3d). In this simulation, Yv measurements were relatively robust to the
kernel sizes considered, and the 32×32 filter choice resulted in less than one percentage
point oxygen saturation of bias towards an overestimation of Yv. This suggests that our
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processing with a 32×32 Hanning filter has only a small effect on the relevant phase
difference Δϕvein-tissue in identified narrow vessels.
For all identified vessels, Δϕvein-tissue was measured at each acquired TE. Phase inside the
vein (ϕvein) was estimated using the brightest pixel observed, or in some cases the average of
up to 4 bright pixels of similar value for the largest vessels, to avoid bias from partial-
volume effects (Fig. 2d). ΔBvein-tissue was calculated through a linear fit of Δϕvein-tissue
across TE’s, where the fit was constrained such that Δϕvein-tissue = 0 at TE = 0. The
corresponding Yv was quantified only for vessels that demonstrated a robust fit for
ΔBvein-tissue, as determined by an R2 value greater than 0.95. The constraint at TE = 0 was
introduced as a physically realistic prior that we expect to reduce the variance of our phase
estimates and not introduce biases. Table 1 compares Yv values calculated using the
constrained linear fit with Yv values from an unconstrained linear fit in eight candidate veins
from Subject 1. The mean Yv observed in the subject using the constraint (61.1 ± 6.4%) was
not statistically significant from the mean Yv measured without the constraint (60.3 ±
10.5%, p = 0.85). In addition, the mean extrapolated phase value at TE = 0 in the
unconstrained fit was not significantly different from 0, as expected (p = 0.74). However,
using the constraint at TE = 0 decreased the standard deviation on Yv estimates for Subject 1
by several percent points oxygenation. As a design choice, the current method thus imposes
the constraint at TE = 0 to improve the robustness of the Yv estimates.
Quantitative CBF maps were generated from the average difference signal (ΔM) between
control and tag images in the ASL acquisition as (26):
[4]
where the longitudinal relaxation of blood was assumed to be T1b = 1684 ms at 3 Tesla (31).
Regional perfusion for each vein was determined by averaging CBF values from a local
region of interest (ROI) in the appropriate CBF slice. The selected ROIs had an average
volume of 253 ± 87 mm3 and were chosen in the spatial neighborhood around the candidate
veins identified in the FLASH image (Fig. 2c). Additional examples of identified vessels
and the corresponding ROI determined in the CBF map are presented in Fig. 4. Regional
CMRO2 was then calculated for the tissue surrounding each candidate vessel using the
measured Yv and local CBF.
Signal-to-noise ratio (SNR) analysis for Yv measurements
Simulations were performed to assess the effect of thermal noise on the Yv measurements.
Assuming sufficiently high magnitude SNR (>2), the phase standard deviation is well
estimated for each imaging TE as (32):
[5]
where σnoise is the standard deviation of Gaussian noise in the real and imaginary
components of the MR signal and | I | is the magnitude image intensity. In the simulation,
image intensity was calculated as | I | = 1000·exp( −TE/T2*blood ), where the T2* relaxation
of blood (T2* blood) was determined empirically from the gradient echo data using an ROI
within the sagittal sinus. The mean T2*blood measured across subjects was 24.7 ± 3.8 ms.
The calculated σphase at each TE was propagated to reveal the expected variation in
measured Yv as a function of SNR (Fig. 5). To compare with the simulation results, the SNR
associated with the Yv measurements in vivo was also determined. The σnoise for each
subject was estimated from an ROI outside of the brain in the complex gradient echo signal.
Signal intensity was recorded from the voxels associated with the ϕvein measurements,
which informed the range of SNR observed in the Yv estimates in vivo.
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RESULTS
Table 2 describes the mean gray matter Yv, CBF, and CMRO2 measured in each subject
using the proposed technique. For each subject, an average of 8.5 ± 2 vessels were identified
for analysis within the imaging slab. A gray matter estimate for each parameter was made by
averaging over measurements in the frontal, temporal, and occipital lobes in each volunteer.
Study averages across subjects were 59.7 ± 2.4% for Yv, 49.8 ± 5.5 ml/100g/min for CBF,
and 151 ± 15 μmol/100g/min for CMRO2 (mean ± SD, n=12).
To evaluate the robustness of the method in quantifying Yv, we propagated the effect of
noise on the oxygenation measurements from phase. Results from simulations showed that
the standard deviation in our Yv estimates due to noise was less than 5% percentage points
oxygen saturation for SNR as low as 10. The SNR simulation was repeated for vessel tilt
angles of 0, 5, and 10° to jointly assess thermal noise and vessel orientation as sources of
error, as in Fig. 6. The gradient echo measurements in vivo had average SNR in the range of
40–70. From these simulations, we expect the bias in Yv measurements due to vessel tilt to
dominate the error from thermal noise within this SNR range (Fig. 6).
Since we quantified several different parameters describing brain physiology, it is
interesting to study the relationships between the measured parameters. Estimates of Yv and
CBF were acquired independently in our technique, and a positive correlation between the
two parameters was observed across subjects in Fig. 7a (R2=0.41, p<0.03). This suggests
that subjects with higher cerebral perfusion tend to have higher oxygenation, which is
consistent with correlations reported in previous studies (16,17). A positive correlation was
also observed between CBF and CMRO2 (R2=0.49, p<0.02) in Fig. 7b, suggesting that
absolute estimates of CMRO2 are highly dependent on perfusion. There was no correlation
between measurements of Yv and CMRO2.
The absolute CMRO2 values measured with PROM comport with results from previous
work by both PET and MRI (Fig. 8). Our gray matter CMRO2 measurement agreed well
with gray matter values determined by PET (11,12), and was greater than global estimates
previously described by MRI (16,17). Across the studies considered here, the average
CMRO2 in gray matter was 159 ± 3 μmol/100g/min and average whole-brain CMRO2 was
131 ± 8 μmol/100g/min. This is consistent with the idea that whole-brain CMRO2
measurements also include white matter metabolism, which is known to be lower than gray
matter metabolism (10,13).
We were also interested to see if PROM could detect any regional differences in brain
physiology at rest. In 11 of the 12 subjects, two or more representative vessels were
identified in the frontal, temporal, and occipital lobes. Care was taken to manually attribute
suitable veins to the appropriate region, as illustrated in Fig. 9. Averages of the parameters
of interest in the three regions were computed for each subject and compared using a one-
way ANOVA analysis across subjects. Significantly greater CBF and CMRO2 (p<0.01)
were detected in the occipital cortex compared to the frontal and temporal cortices at rest
(Table 3). This may reflect increased perfusion and metabolism in visual areas associated
with the occipital lobe. However, no statistical differences were observed in Yv across the
three regions. The spatial variations in oxygen consumption and flow observed with PROM
in the resting cortex agree well with those reported by Ishii et al. using 15O PET imaging
(11), and values from both studies for the same regions are presented in Table 3.
DISCUSSION
We have developed a technique using MRI to quantify local Yv and CMRO2 in the brain
and demonstrated the method on human volunteers. The method builds on previous work to
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measure global oxygenation and metabolism in the sagittal sinus using TRUST and
susceptometry in MRI (16,17). In contrast to the global values derived from sagittal sinus
measurements, regional estimates of these physiological parameters are currently
unavailable using noninvasive techniques, and have the potential to provide novel
information about brain function and disease. The proposed technique is readily applicable
on clinical scanners because it uses standard GRE and ASL sequences for data acquisition.
Although the current protocol is relatively lengthy (approximately 25 minutes), improved
implementation of a flow-compensated, multi-echo FLASH sequence will substantially
reduce scantime for clinical applications. Estimates of gray matter Yv, CBF, and CMRO2
using PROM lie within the normal physiological range reported in the literature and show
promise in detecting regional differences in physiology across the brain. Future work will
cross-validate regional CMRO2 values from PROM with the proposed T2-based
QUIXOTIC method (20), which uses velocity-selective arterial spin labeling to quantify the
rate of oxygen metabolism.
In this study, positive correlation was observed between the mean Yv and CBF, as well as
between the mean CMRO2 and CBF estimated across subjects. This agrees with work by Xu
et al., which reported positive correlations between the parameters using whole-brain
estimates for CMRO2 with TRUST MRI (16). We also observed significantly greater CBF
and CMRO2 in the occipital cortex, where visual function is localized, compared to the
frontal and temporal cortices. Oxygen saturation, however, remained relatively constant
across the three regions analyzed. These findings are concordant with previous results from
PET imaging (11), and are relevant to ongoing work studying the distribution of oxidative
and non-oxidative metabolic pathways to meet cerebral energy demands (33,34). Regional
variations in metabolic pathways may represent differential mechanisms in response to
energy needs associated with specific brain systems (33) or to local, task-induced energy
demands (34). Application of PROM for regional quantification of oxygen metabolism at
rest and during functional activity may provide further insight into spatial variations in
metabolic pathways across the brain.
In the current method, Yv estimates were made from phase measurements using assumed
values for the susceptibility difference between fully oxygenated and fully deoxygenated
blood (Δχdo) and hematocrit (Hct). Here we chose Δχdo = 0.18 ppm for consistency with
several values commonly used the literature (23,35,36), and this particular value has been
used in MR susceptometry to provide meaningful estimates of oxygenation in cerebral pial
veins (21) and in the internal jugular vein (22). In recent literature, Spees et al. (37) reported
an alternate value of Δχdo = 0.27ppm, which has also been used for Yv measurements in
femoral vessels (27) and in large draining veins of the brain (17). We note that using Δχdo =
0.27 ppm in our analysis would lead to a mean absolute Yv of 73% for this study, which is
higher than the normal blood oxygenation observed using MRI and PET. This choice of
susceptibility value will be evaluated in future work in light of its impact on quantitative Yv
results. In addition, in this work hematocrit values were assumed, with Hct = 0.42 for males
and Hct = 0.38 for females. Hematocrit is largely variable between individuals, typically
ranging from 0.35–0.50, and we propose to measure this parameter in each subject using a
finger prick device to refine oxygenation estimates in future studies.
For Yv estimates in this work, we have assumed that arterial blood is fully oxygenated, and
that cerebral tissue has the same susceptibility as arterial blood. This is a reasonable
assumption for healthy subjects, and empirically, there is little phase contrast between
arteries and tissue. However, this assumption may no longer hold in pathology or in hypoxia
when arterial blood is no longer fully oxygenated. In addition, because this analysis focused
on candidate gray matter veins in young subjects, the results do not take into account
regional variations in tissue susceptibility or changes with age. For instance, Duyn et al.
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have measured a small susceptibility difference between gray matter and white matter, on
the order of 0.02ppm (38), and larger susceptibility values on the order of 0.1ppm are
observed in iron-rich structures in the basal ganglia. This literature suggests that tissue
susceptibility distributions can be determined to refine phase measurements for Yv
estimation across different regions of the brain.
To quantify CMRO2 in this study, the Fick principle of arteriovenous difference was used to
relate CMRO2 to Yv and CBF. In the PROM approach, CBF measurements were made
using perfusion imaging with ASL, which is sensitive to the delivery of arterial blood to the
capillary bed and appropriately characterizes the rate of delivery of oxygenated blood to
brain tissue. It is important to note that an alternate method to measure CBF, used by Jain et
al. (17), measures blood flow velocity with MRI phase-contrast and calculates CBF with an
additional estimate of the corresponding brain volume. Both approaches ultimately aim to
estimate the rate of inflow of oxygen-rich blood accessible to cerebral tissue, and ideally
provide concordant information about global CBF in larger vessels. However, to our
knowledge, local CBF as measured using ASL in ml/100g/min is difficult to estimate from
vessel flow velocity without an additional measurement of local tissue volume.
One current limitation of our technique is its restrictive dependence on vessel geometry and
orientation. To simplify the quantification of susceptibility differences between the
vasculature and the surrounding tissue, we made two assumptions. First, we have focused
only on vessel segments that are narrow relative to their length, and can thus be modeled as
an infinite cylinder. Secondly, we only consider vessel segments parallel to the main
magnetic field. These conditions naturally limit the set of vessels that can be analyzed with
the current method, and in some subjects as few as 6 suitable vessels were identified within
the 20mm-thick imaging slab. Although an appropriate candidate vein was typically present
in each major lobe within the slab, the condition of long, parallel vessel remains an
important limitation to the current method. In addition, MR susceptometry with this model
may introduce bias to the Yv measurements depending on how well the assumptions hold.
Previous work on femoral vessels in vivo revealed that the long cylinder model is valid for
length-to-diameter ratio as low as 6, and found only a few percent variation in measured
oxygenation due to vessel tilt as large as 20° (27). Based on the SNR simulations presented
here, we expect the variation in Yv due to noise with our current acquisition to be small (less
than ~5%). Most of our error is expected to be from bias due to the vessel geometry model,
such as in cases when the vessel is tilted with respect to the main field. These considerations
suggest that the vessel model is valid for measurements of oxygenation and that it can be
refined appropriately to reduce errors for veins in vivo with tilt angles that deviate from
zero.
Extension of phase-based Yv estimates to vein segments with arbitrary tilt or geometry
would require more complex models to account for the field external to the vessel and
changes in SNR along the vessel length. Susceptibility measurements from phase are often
noisier for such vessels because the imaging dipole kernel undersamples the susceptibility
distribution in k-space (39). In particular, spatial frequency data from vein segments
oriented at or close to a conical surface along the magic angle of 54.7° in k-space is mostly
lost. To address these considerations, we will pursue development of quantitative
susceptibility mapping (QSM) for vessels with general curvature, along similar lines to
techniques currently being developed iron quantification in the brain (39,40). In particular,
L1-norm regularization of the inversion of field maps to susceptibility maps have been
successful in mapping regional iron deposition (39). From magnetostatics, susceptibility
shifts are understood to cause perturbations in the main magnetic field as well as T2* decay.
Because susceptibility shifts that are not manifested in T2* images are spatially smooth, and
therefore “sparse” in an appropriate basis, L1-norm regularization can be used to fit for a
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spatial susceptibility distribution. We therefore suggest the use of QSM to extend our
analysis of Yv to a larger set of vessels with arbitrary orientation and geometry. Another
potential benefit of QSM is to reduce the error margin on Yv measurements by averaging
susceptibility values reconstructed by the algorithm along curved vessels.
Adequate spatial resolution in phase images is critical for accurate oxygenation
measurements in this work. To avoid bias from partial volume effects, in some cases phase
inside the vein was measured from the brightest observed pixel for narrow vessels, as in Fig.
2b. However, for smaller vessels that do not meet a critical minimum diameter, partial-
volume effects may distort phase measurements and result in overestimation of Yv. The
relatively high SNR in our current gradient echo acquisition suggests that the resolution of
phase images can be improved for measurements of Yv. PROM can take advantage of
improved SNR at higher field such as 7 Tesla for enhanced spatial resolution. A critical
benefit of the higher resolution is mitigation of partial-volume effects, and the improved
spatial resolution will allow analysis of smaller cerebral veins expected to be more
indicative of regional brain function and the ability to process a larger set of vessels. In the
current technique, acquired phase images are processed with a homodyne high pass filter (32
× 32 Hanning). This filtering technique is suboptimal because suppression of low spatial
frequencies inherently depends on the filter size and may not always provide adequate
reduction of background inhomogeneities, which vary from subject to subject (41).
Improved filtering approaches such as dipole fitting to the background field (42) and
optimized phase reconstruction using multi-channel coil sensitivity information (43), will be
the focus of refinements to the filtering algorithm. We note that main field and RF field
inhomogeneities are likely to pose a more severe problem at high field and that more
elaborate processing may be needed for the quantification of Yv.
Another limitation of our method is the relatively low resolution of CBF maps from which
local perfusion values are quantified. ASL intrinsically has low SNR because the perfusion
weighting in the ASL difference signal derives from small CBF-dependent changes between
control and tag images. At 3 Tesla, our ASL acquisition uses in-plane resolution that is four
times lower than the GRE sequence and has twice the slice thickness. Although the ROIs in
the perfusion maps were selected in the spatial neighborhood of candidate gray matter veins,
it is likely that the technique averages gray and white matter perfusion to some degree in
quantifying local CBF due to its low resolution. ASL performance can be enhanced using
3D readouts such as 3D GRASE for improved spatial and temporal SNR, shorter scan time,
and elimination of slice-dependent effects (44). Future implementation of ASL at 7 Tesla
also offers improved resolution due to increased SNR and shorter longitudinal relaxation
times at higher field strength (45).
Improved spatial resolution in ASL is important to identifying the drainage territory for each
vein, which is not fully understood in the current method. Although ROIs in the CBF maps
were in the spatial neighborhood of identified veins, this region may not be the physiological
draining territory for the corresponding vessels. For instance, the vein may drain upstream
areas and not the local tissue to which it is spatially matched. The true physiological region
of drainage likely depends on vessel size and its position within the vasculature, and
determines the optimal ROI for accurate local CBF measurements. Improved resolution
would allow for more sophisticated segmentation of ASL images and coregistration between
CBF maps and phase images. This would allow us to trace candidate pial veins within the
slab of interest and make an educated selection of the local perfusion territory for each
vessel. Knowledge of vessel drainage in future work would improve matching of perfusion
values in tissue to appropriate cerebral veins, and potentially extend PROM to create maps
of local CMRO2 in the brain.
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CONCLUSIONS
This work demonstrates that PROM, the proposed method, can provide regional estimates of
blood oxygenation, blood flow, and oxygen metabolism in the brain. The technique is
noninvasive and straightforward to implement, and can provide information about local
changes in cerebral physiology during functional activation and in cases of disease that
disrupt cerebral metabolism.
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Figure 1.
Orientation and geometry of candidate cerebral vein in gradient echo images. (a) Sagittal
view of minimum intensity projection of the magnitude image. (b) Sagittal view of
maximum intensity projection of the phase image. The rectangle highlights a vessel of
interest for which (c) magnitude; and (d) phase are depicted. The arrow indicates the region
for which the vein is approximately a narrow cylinder parallel to B0.
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Figure 2.
Illustration of PROM for quantification of Yv and CMRO2. (a) Axial magnitude; and (b)
phase image from a 2D gradient echo acquisition. The rectangle highlights a through-plane
gray matter vein of interest. (c) CBF map (ml/100g/min) from the corresponding slice in
ASL acquisition with ROI used to measure regional perfusion of the identified vessel. (d)
Zoomed view magnitude and phase (in radians) for the gray matter vein, where ϕvein is the
representative phase value within the vessel.
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Figure 3.
Comparison of Yv measurements for different Hanning high pass filter sizes. (a) Sagittal
slice of the simulated background field map (ppm) from assumed values for susceptibility of
brain tissue, χtissue = −9.05ppm, and susceptibility of the air outside the brain, χair =
0.36ppm. (b) Simulated axial phase image at TE = 10ms before filtering; the rectangle
indicates the ROI containing the simulated parallel vein. (c) Zoomed phase ROI with vessel
(arrow) for TE = 10ms after high-pass filtering with Hanning kernel sizes of NxN = 4×4,
8×8, 16×16, and 32×32. (d) Yv estimates using a linear fit of simulated Δϕvein-tissue across
TE for each Hanning filter size.
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Figure 4.
Additional examples of identified candidate vessels (arrows) in axial phase images from
Subject 3 (a) and Subject 4 (c), acquired at TE = 20ms. (b,d) The corresponding CBF
regions of interest identified for regional perfusion measurements.
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Figure 5.
Simulated phase and standard deviation across TE for true Yv = 60% and representative
magnitude SNR = 40 (at TE=10ms), which was typical for the in vivo acquisitions presented
here. The zoomed inset illustrates the variation in estimated Yv between 58.8% and 61.2%
due to thermal noise.
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Figure 6.
Expected measurement error in % oxygenation due to noise as a function of SNR. Separate
curves are plotted for vessel tilt angles of 0, 5, and 10°. The arrow indicates the typical SNR
range for the gradient echo acquisition, suggesting a larger bias due to vessel geometry than
uncertainty due to Gaussian noise in the Yv measurements.
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Figure 7.
Correlation of subject means for physiological parameters. (a) Scatter plot of average CBF
and Yv, indicating a positive correlation between the parameters across subjects (R2=0.41,
p<0.03). (b) Scatter plot of average CBF and CMRO2, indicating that CMRO2 values are
dependent on perfusion across subjects (R2=0.49, p<0.02).
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Figure 8.
Comparison of mean CMRO2 in whole brain [Mintun 1984 (10); Hattori 2004 (12); Ito 2005
(13); Xu 2009 (16); Jain 2010 (17)] and gray matter [Ishii 1996 (11); Ibaraki 2008 (14)]
reported in literature. Previous MRI estimates are for global CMRO2, whereas the PROM
estimate is an average across gray matter regions.
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Figure 9.
Example cerebral vessels identified in the frontal, temporal, and occipital cortices of the
gradient echo image for regional analysis. Corresponding ROIs in the CBF map from ASL
are shown.
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Table 1
Estimates of Yv in eight parallel vessels for Subject 1
Vessel Yv (%)(Constrained at TE = 0) Yv (%)(Not constrained at TE = 0) Fitted phase (rad) at TE = 0
1 56.9 46.8 −0.45
2 51.2 42.5 −0.38
3 66.8 71.2 0.20
4 67.0 60.3 −0.31
5 67.3 63.4 −0.17
6 54.8 60.8 0.27
7 65.5 70.8 0.24
8 59.5 66.5 0.30
Mean 61.1 ± 6.4 60.3 ± 10.5 −0.04 ± 0.32
Mean Yv estimated from the constrained fit was not significantly different from mean Yv measured using the unconstrained fit (p=0.85). Mean
phase at TE=0 for the unconstrained fit was not statistically different from 0 (p=0.74).
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Table 2
Summary of Yv and CMRO2 measurements in gray matter (n=12)
Subject Yv (%) CBF (ml/100g/min) CMRO2 (μmol/100g/min)
1 61 ± 6 52 ± 8 146 ± 33
2 64 ± 4 58 ± 7 165 ± 28
3 58 ± 4 52 ± 9 174 ± 38
4 58 ± 3 51 ± 11 153 ± 34
5 56 ± 4 44 ± 8 155 ± 34
6 58 ± 3 41 ± 5 134 ± 12
7 61 ± 2 53 ± 7 162 ± 17
8 61 ± 4 55 ± 11 155 ± 33
9 62 ± 4 49 ± 6 133 ± 18
10 58 ± 3 46 ± 6 151 ± 22
11 59 ± 3 42 ± 4 123 ± 17
12 60 ± 4 56 ± 9 162 ± 36
Mean 59.7 ± 2.4 49.8 ± 5.5 151 ± 15
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Table 3
For the PROM study, one way ANOVA analyses were used to compare each parameter across the three
regions.
Parameter Frontal Temporal Occipital
PROM Yv (%) 60.8 ± 3 59.5 ± 3 59.3 ± 3
CBF (ml/100g/min) 43.9 ± 6 45.7 ± 4 54.1 ± 7 **
CMRO2 (μmol/100g/min) 130 ± 17 140 ± 17 166 ± 18 **
Ishii et al., 1996 Yv (%) 59.4 ± 7 58.7 ± 7 58.7 ± 6
CBF (ml/100g/min) 54.8 ± 9 56.3 ± 9 66.1 ± 13 *
CMRO2 (μmol/100g/min) 160 ± 27 169 ± 32 194 ± 46 *
*
(p < 0.05),
**
(p< 0.01).
Magn Reson Med. Author manuscript; available in PMC 2013 March 1.
